The report is titled as ‘Tumor Ablation Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the tumor ablation market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Tumor ablation market is expected to grow with significant rate in the near future.
The global tumor ablation market in 2020 is estimated for more than US$ 1.3 Bn and expected to reach a value of US$ 3.0 Bn by 2028 with a significant CAGR of 11.1%
MMC Overview
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Tumor Ablation market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Tumor Ablation Market Key Players
Some of the key participating players in global tumor ablation market are
Medtronic plc
Angiodynamics, Inc.
Boston Scientific Corporation
Galil Medical, Inc.
EDAP TMS S.A.
Healthtronics, Inc.
Mermaid Medical, Inc.
Mesonix, Inc.
Neuwave Medical, Inc.
Sonacare Medical, LLC
Tumor Ablation Market Segmentation
The global tumor ablation market is segmented on the basis of technology, mode of treatment, application, and region.
On Basis of Technology
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
On Basis of Mode of Treatment
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation
On Basis of Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Metastasis
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
1. Global Tumor Ablation Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Tumor Ablation Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Tumor Ablation Market Snapshot
2.4. Global Tumor Ablation Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Tumor Ablation Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Tumor Ablation Market, By Technology
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Technology
3.1.2. BPS Analysis, By Technology
3.2. Market Revenue (US$Mn) Forecast, By Technology
3.2.1. Radiofrequency (RF) Ablation
3.2.2. Microwave Ablation
3.2.3. Cryoablation
3.2.4. Other Technologies
3.3. Global Tumor Ablation Market Attractiveness Index, By Technology
4. Global Tumor Ablation Market, By Mode of Treatment
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Mode of Treatment
4.1.2. BPS Analysis, By Mode of Treatment
4.2. Market Revenue (US$Mn) Forecast, By Mode of Treatment
4.2.1. Surgical Ablation
4.2.2. Laparoscopic Ablation
4.2.3. Percutaneous Ablation
4.3. Global Tumor Ablation Market Attractiveness Index, By Mode of Treatment
5. Global Tumor Ablation Market, By Application
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Application
5.1.2. BPS Analysis, By Application
5.2. Market Revenue (US$Mn) Forecast, By Application
5.2.1. Liver Cancer
5.2.2. Lung Cancer
5.2.3. Kidney Cancer
5.2.4. Bone Metastasis
5.2.5. Others
5.3. Global Tumor Ablation Market Attractiveness Index, By Application
6. Global Tumor Ablation Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Tumor Ablation Market Attractiveness Index, By Region
7. North America Tumor Ablation Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Tumor Ablation Market
7.2.2. Canada Tumor Ablation Market
7.3. North America Tumor Ablation Market, By Technology
7.3.1. Radiofrequency (RF) Ablation
7.3.2. Microwave Ablation
7.3.3. Cryoablation
7.3.4. Other Technologies
7.4. North America Tumor Ablation Market, By Mode of Treatment
7.4.1. Surgical Ablation
7.4.2. Laparoscopic Ablation
7.4.3. Percutaneous Ablation
7.5. North America Tumor Ablation Market, By Application
7.5.1. Liver Cancer
7.5.2. Lung Cancer
7.5.3. Kidney Cancer
7.5.4. Bone Metastasis
7.5.5. Others
7.6. North America Tumor Ablation Market Attractiveness Index
7.6.1. By Country
7.6.2. By Technology
7.6.3. By Mode of Treatment
7.6.4. By Application
8. Latin America Tumor Ablation Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Tumor Ablation Market
8.2.2. Mexico Tumor Ablation Market
8.2.3. Argentina Tumor Ablation Market
8.2.4. Rest of Latin America Tumor Ablation Market
8.3. Latin America Tumor Ablation Market, By Technology
8.3.1. Radiofrequency (RF) Ablation
8.3.2. Microwave Ablation
8.3.3. Cryoablation
8.3.4. Other Technologies
8.4. Latin America Tumor Ablation Market, By Mode of Treatment
8.4.1. Surgical Ablation
8.4.2. Laparoscopic Ablation
8.4.3. Percutaneous Ablation
8.5. Latin America Tumor Ablation Market, By Application
8.5.1. Liver Cancer
8.5.2. Lung Cancer
8.5.3. Kidney Cancer
8.5.4. Bone Metastasis
8.5.5. Others
8.6. Latin America Tumor Ablation Market Attractiveness Index
8.6.1. By Country
8.6.2. By Technology
8.6.3. By Mode of Treatment
8.6.4. By Application
9. Europe Tumor Ablation Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Tumor Ablation Market
9.2.2. Germany Tumor Ablation Market
9.2.3. Italy Tumor Ablation Market
9.2.4. France Tumor Ablation Market
9.2.5. Spain Tumor Ablation Market
9.2.6. Russia Tumor Ablation Market
9.2.7. Poland Tumor Ablation Market
9.2.8. BENELUX Tumor Ablation Market
9.2.9. NORDIC Tumor Ablation Market
9.2.10. Rest of Europe Tumor Ablation Market
9.3. Europe Tumor Ablation Market, By Technology
9.3.1. Radiofrequency (RF) Ablation
9.3.2. Microwave Ablation
9.3.3. Cryoablation
9.3.4. Other Technologies
9.4. Europe Tumor Ablation Market, By Mode of Treatment
9.4.1. Surgical Ablation
9.4.2. Laparoscopic Ablation
9.4.3. Percutaneous Ablation
9.5. Europe Tumor Ablation Market, By Application
9.5.1. Liver Cancer
9.5.2. Lung Cancer
9.5.3. Kidney Cancer
9.5.4. Bone Metastasis
9.5.5. Others
9.6. Europe Tumor Ablation Market Attractiveness Index
9.6.1. By Country
9.6.2. By Technology
9.6.3. By Mode of Treatment
9.6.4. By Application
10. Asia Pacific Tumor Ablation Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Tumor Ablation Market
10.2.2. India Tumor Ablation Market
10.2.3. Japan Tumor Ablation Market
10.2.4. Australia and New Zealand Tumor Ablation Market
10.2.5. South Korea Tumor Ablation Market
10.2.6. ASEAN Tumor Ablation Market
10.2.7. Rest of Asia Pacific Tumor Ablation Market
10.3. Asia Pacific Tumor Ablation Market, By Technology
10.3.1. Radiofrequency (RF) Ablation
10.3.2. Microwave Ablation
10.3.3. Cryoablation
10.3.4. Other Technologies
10.4. Asia Pacific Tumor Ablation Market, By Mode of Treatment
10.4.1. Surgical Ablation
10.4.2. Laparoscopic Ablation
10.4.3. Percutaneous Ablation
10.5. Asia Pacific Tumor Ablation Market, By Application
10.5.1. Liver Cancer
10.5.2. Lung Cancer
10.5.3. Kidney Cancer
10.5.4. Bone Metastasis
10.5.5. Others
10.6. Asia Pacific Tumor Ablation Market Attractiveness Index
10.6.1. By Country
10.6.2. By Technology
10.6.3. By Mode of Treatment
10.6.4. By Application
11. Middle East Tumor Ablation Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Tumor Ablation Market
11.2.2. Israel Tumor Ablation Market
11.2.3. Oman Tumor Ablation Market
11.2.4. Rest of Middle East Tumor Ablation Market
11.3. Middle East Tumor Ablation Market, By Technology
11.3.1. Radiofrequency (RF) Ablation
11.3.2. Microwave Ablation
11.3.3. Cryoablation
11.3.4. Other Technologies
11.4. Middle East Tumor Ablation Market, By Mode of Treatment
11.4.1. Surgical Ablation
11.4.2. Laparoscopic Ablation
11.4.3. Percutaneous Ablation
11.5. Middle East Tumor Ablation Market, By Application
11.5.1. Liver Cancer
11.5.2. Lung Cancer
11.5.3. Kidney Cancer
11.5.4. Bone Metastasis
11.5.5. Others
11.6. Middle East Tumor Ablation Market Attractiveness Index
11.6.1. By Country
11.6.2. By Technology
11.6.3. By Mode of Treatment
11.6.4. By Application
12. Africa Tumor Ablation Market Analysis and Forecast, 2020–2028
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Tumor Ablation Market
12.2.2. Egypt Tumor Ablation Market
12.2.3. North Africa Tumor Ablation Market
12.2.4. Rest of Africa Tumor Ablation Market
12.3. Africa Tumor Ablation Market, By Technology
12.3.1. Radiofrequency (RF) Ablation
12.3.2. Microwave Ablation
12.3.3. Cryoablation
12.3.4. Other Technologies
12.4. Africa Tumor Ablation Market, By Mode of Treatment
12.4.1. Surgical Ablation
12.4.2. Laparoscopic Ablation
12.4.3. Percutaneous Ablation
12.5. Africa Tumor Ablation Market, By Application
12.5.1. Liver Cancer
12.5.2. Lung Cancer
12.5.3. Kidney Cancer
12.5.4. Bone Metastasis
12.5.5. Others
12.6. Africa Tumor Ablation Market Attractiveness Index
12.6.1. By Country
12.6.2. By Technology
12.6.3. By Mode of Treatment
12.6.4. By Application
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Medtronic plc
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Technology Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Angiodynamics, Inc.
14.3.3. Boston Scientific Corporation
14.3.4. Galil Medical, Inc.
14.3.5. EDAP TMS S.A.
14.3.6. Healthtronics, Inc.
14.3.7. Mermaid Medical, Inc.
14.3.8. Mesonix, Inc.
14.3.9. Neuwave Medical, Inc.
14.3.10. Sonacare Medical, LLC
15. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global tumor ablation market in 2020 is estimated for more than US$ 1.3 Bn and expected to reach a value of US$ 3.0 Bn by 2028 with a significant CAGR of 11.1%
What technology segment include in the report?
The technology segment includes Radiofrequency (RF) Ablation, icrowave Ablation, Cryoablation, and Other Technologies
What segments are covered in market report?
The global tumor ablation market is segmented on the basis of technology, mode of treatment, application, and region.
What are the key participating players in the market?
Some of the key participating players in global tumor ablation market are Medtronic plc, Angiodynamics, Inc., Boston Scientific Corporation, Galil Medical, Inc., EDAP TMS S.A., Healthtronics, Inc., Mermaid Medical, Inc., Mesonix, Inc., Neuwave Medical, Inc., and Sonacare Medical, LLC
